influenzalik
ill
ili
nonspecif
respiratori
ill
defin
fever
cough
andor
pharyng
track
center
diseas
control
prevent
cdc
influenza
surveil
system
laboratori
diagnosi
ili
typic
perform
viru
isol
cell
cultur
antigen
masstag
polymerasechainreact
detect
respiratori
pathogen
includ
new
rhinoviru
genotyp
caus
influenzalik
ill
new
york
state
new
york
state
winter
high
incid
influenzalik
ill
test
neg
influenza
viru
molecular
method
respiratori
virus
viru
cultur
concern
novel
pathogen
might
implic
led
us
implement
new
multiplex
diagnost
tool
masstag
polymeras
chain
reaction
resolv
previous
neg
sampl
reveal
presenc
rhinovirus
larg
proport
sampl
half
belong
previous
uncharacter
genet
clade
instanc
knowledg
detect
viral
andor
bacteri
co
infect
could
alter
clinic
manag
influenzalik
ill
ili
nonspecif
respiratori
ill
defin
fever
cough
andor
pharyng
track
center
diseas
control
prevent
cdc
influenza
surveil
system
laboratori
diagnosi
ili
typic
perform
viru
isol
cell
cultur
antigen
detect
nucleic
acidamplif
method
singleplex
polymeras
chain
reaction
pcr
although
multiplex
nucleic
acidamplif
system
simultan
detect
multipl
respiratori
pathogen
describ
yet
wide
implement
primarili
reason
complex
cost
recent
describ
inexpens
sensit
highli
multiplex
system
differenti
diagnosi
infecti
diseas
masstag
pcr
detect
differ
respiratori
viral
bacteri
pathogen
cultur
isol
respiratori
specimen
infect
individu
masstag
pcr
also
detect
relev
pathogen
specimen
patient
ebola
marburg
lassa
rift
valley
crimeancongo
hemorrhag
fever
new
york
state
ny
winter
high
incid
ili
test
neg
influenza
viru
fluav
b
flubv
realtim
revers
transcript
rt
pcr
respiratori
virus
convent
viru
cultur
concern
find
reflect
circul
novel
pathogen
led
us
perform
masstag
pcr
analys
patient
materi
method
patient
ili
identifi
visit
ny
healthcar
provid
belong
cdc
influenza
sentinel
physician
network
influenza
season
octob
may
respiratori
oropharyng
nasopharyng
nasal
swab
transport
medium
remel
patient
studi
month
year
old
median
age
year
penicillin
streptomycin
mycostatin
ad
specimen
latter
inocul
primari
rhesusmonkey
kidney
rhmk
cell
convent
viru
cultur
addit
sampl
test
presenc
fluav
flubv
either
direct
antigen
detect
bd
directigen
realtim
rtpcr
assay
primer
probe
sequenc
provid
cdc
laboratori
respons
network
http
wwwbtcdcgovlrn
realtim
rtpcr
rna
extract
ml
specimen
use
viralrna
kit
qiagen
elut
volum
qiagen
inocul
rhmk
cell
observ
timesweek
week
determin
cytopath
effect
day
cultur
test
hemadsorpt
posit
cultur
assay
influenza
parainfluenza
virus
direct
immunofluoresc
assay
chemicon
cytopath
effect
observ
absenc
hemadsorpt
immu
nofluoresc
assay
use
test
cell
adenoviru
chemicon
herp
simplex
microtrack
total
nucleic
acid
extract
ml
specimen
nuclisen
magnet
extract
method
elut
volum
extract
sampl
spike
transcript
encod
portion
greenfluoresc
protein
control
extract
effici
absenc
rtpcr
inhibitor
masstag
pcr
assay
target
follow
respiratori
pathogen
fluav
flubv
human
respiratori
syncyti
virus
b
human
coronavirus
sar
human
parainfluenza
virus
human
metapneumoviru
hmpv
human
enteroviru
hev
human
adenoviru
hadv
mycoplasma
pneumonia
legionella
pneumophila
chlamydia
pneumonia
streptococcu
pneumonia
haemophilu
influenza
neisseria
meningitidi
primer
pair
target
greenfluorescentprotein
qualitycontrol
sequenc
also
includ
masstag
pcramplif
product
analyz
singlequadrapol
mass
spectromet
use
positivemod
atmosphericpressur
chemic
ioniz
agil
technolog
sampl
masstag
pcr
test
posit
pneumonia
l
pneumophila
c
pneumonia
n
meningitidi
hev
hadv
also
test
pathogen
realtim
pcr
assay
ny
depart
health
clinic
laboratori
evalu
program
approv
clinic
use
publish
pcr
assay
use
sampl
posit
human
coronavirus
h
influenza
type
b
c
pneumonia
serotyp
gene
region
picornavirus
amplifi
describ
elsewher
masstag
pcramplif
product
influenza
virus
clone
pgemteasi
plasmid
vector
promega
sequenc
dideoxi
sequenc
abi
genet
analyz
sequenc
analyz
appli
biosystem
sequenc
analyz
use
wisconsin
gcg
softwar
packag
accelri
mega
http
www
megasoftwarenet
result
influenza
season
ny
depart
health
receiv
sampl
influenza
sentinel
physician
surveil
network
includ
present
studi
sampl
analyz
arriv
laboratori
antigendetect
realtim
rtpcr
assay
design
identifi
influenza
virus
well
convent
viru
cultur
detect
addit
respiratoryvir
pathogen
fluav
flubv
n
p
n
p
account
major
identifi
pathogen
addit
hadv
herp
simplex
n
p
n
p
virus
isol
sampl
coinfect
n
p
fluav
flubv
present
summari
analys
identifi
pathogen
sampl
provid
presumpt
diagnosi
case
howev
pathogen
identifi
sampl
sampl
collect
day
onset
symptom
low
microbi
load
time
collect
could
account
neg
result
howev
mani
pathogenneg
sampl
cluster
within
period
octob
decemb
compat
presenc
unidentifi
pathogen
therefor
retrospect
investig
avail
store
specimen
use
multiplex
masstag
pcr
analysi
retrospect
sampl
masstag
pcr
indic
presenc
pathogen
sampl
identifi
pathogen
previous
neg
specimen
tabl
top
case
diagnos
previous
pathogen
detect
sampl
pathogen
identifi
previous
masstag
pcr
reveal
presenc
total
addit
pathogen
tabl
bottom
furthermor
reveal
infect
pathogen
patient
pathogen
patient
hadv
flubv
result
masstag
pcr
assay
concord
realtim
rtpcr
assay
fluav
concord
result
discord
fluav
sampl
realtim
rtpcr
found
posit
viral
load
sampl
indic
realtim
rtpcr
cyclethreshold
valu
data
shown
rna
copiesreact
masstag
pcr
assay
limit
detect
fluav
degener
hev
primer
use
masstag
pcr
assay
target
conserv
region
untransl
region
utr
picornavirus
region
also
present
human
rhinovirus
hrv
sampl
found
posit
test
primer
pair
test
specif
diagnost
realtim
rtpcr
assay
hev
case
yield
neg
result
reason
product
repres
novel
isol
either
hev
hrv
clone
masstag
pcramplif
product
sequenc
analysi
identifi
hev
hrv
tabl
hrv
sequenc
close
relat
mix
popul
hev
hrv
utr
genbank
databas
list
antwerp
rhinoviru
howev
short
utr
sequenc
suitabl
assign
phylogenet
relationship
obtain
addit
sequenc
use
degener
primer
set
target
gene
region
phylogenet
analysi
sequenc
indic
hrv
group
present
case
hrv
group
b
present
case
tabl
instanc
sampl
exhaust
amplif
product
obtain
remain
hrv
case
sequenc
cluster
clade
root
hrv
group
distinct
describ
group
group
b
serotyp
figur
case
specimen
addit
analysi
use
highli
degener
primer
set
allow
amplif
partial
sequenc
analysi
support
phylogenet
posit
indic
analysi
data
shown
discuss
ili
signific
caus
morbid
mortal
unit
state
account
annual
death
hospit
billion
direct
indirect
cost
advent
sensit
afford
method
differenti
diagnosi
infecti
pathogen
caus
ili
potenti
reduc
econom
burden
afford
pathogen
improv
clinic
outcom
facilit
earli
select
appropri
antimicrobi
import
develop
strategi
triag
patient
acut
respiratori
infect
specif
treatment
regimen
underscor
context
pandemicinfluenza
prepared
limit
suppli
influenza
antivir
drug
present
studi
undertaken
investig
caus
ili
ny
period
octob
may
clinic
sampl
obtain
physician
surveil
network
submit
analysi
standard
diagnost
protocol
use
viru
cultur
antigen
detect
molecular
assay
addit
pathogen
identifi
method
masstag
pcr
detect
hrv
hev
pneumonia
pneumonia
h
influenza
hmpv
human
coronaviru
human
respiratori
syncyti
viru
n
meningitidi
infect
masstag
pcr
also
reveal
instanc
virusinfect
patient
ili
coinfect
potenti
treatabl
bacteri
pathogen
unexpect
find
high
incid
rhinoviru
infect
although
rhinovirus
commonli
associ
mild
upperrespiratorytract
diseas
also
describ
associ
sever
acut
lowerrespiratorytract
infect
children
elderli
immunosuppress
patient
present
studi
identifi
new
rhinoviru
genotyp
case
ili
cluster
within
period
octob
decemb
thu
appear
rhinovirus
major
caus
ili
patient
popul
period
vitro
evid
indic
hrv
infect
may
enhanc
probabl
streptococc
infect
upregul
plateletactivatingfactor
receptor
whether
case
coinfect
hrv
pneumonia
observ
present
studi
reflect
similar
interact
pathogen
remain
determin
comprehens
data
requir
role
multipl
infect
play
pathogenesi
respiratori
diseas
assess
object
masstag
pcr
ensur
comprehens
screen
presenc
larg
number
ident
well
relat
genet
target
thu
although
sensit
similar
obtain
realtim
pcr
molecul
primer
target
precis
complementari
accept
primer
optim
perform
detect
threshold
rna
molecul
highli
multiplex
assay
panel
advantag
primer
panel
underscor
observ
identifi
pathogen
previous
neg
sampl
detect
novel
rhinoviru
sequenc
contribut
origin
primer
design
although
setup
cost
masstag
pcr
instrument
current
higher
realtim
pcr
vs
masstag
pcr
compar
favor
system
viru
cultur
differenti
diagnosi
ili
take
week
incur
materi
reagent
cost
altern
rapid
antigendetect
test
perform
within
min
reagent
cost
sensit
viru
cultur
realtim
pcr
assay
gener
sensit
viru
cultur
perform
h
entail
reagent
cost
per
target
contrast
masstag
pcr
requir
h
cost
per
sampl
allow
investig
candid
viral
bacteri
pathogen
singl
reaction
present
studi
confirm
util
masstag
pcr
tool
surveil
detect
outbreak
epidemiolog
potenti
rapidli
analyz
sampl
presenc
wide
rang
candid
viral
bacteri
pathogen
may
act
alon
concert
suggest
may
also
applic
clinic
medicin
